Health product recall

Acid Reducer (Ranitidine) Tablet: N-nitrosodimethylamine (NDMA) impurity

Last updated

Summary

Product
Acid Reducer (Ranitidine) 75 mg Tablet; Maximum Strength Acid reducer (Ranitidine) 150 mg Tablet without prescription
Issue
Health products » Contamination
What to do

See instructions below. 

Affected products

Brand /
Marque

Product Name /
Nom du produit

Market Authorization /
Autorisation de mise en marché

Dosage Form /
Forme posologique

Strength /
Concentration

Lot number /
Numéro de lot

Atoma

ATOMA-ACID RED MAX F 150mg C ALV 3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765H

Option+

OPTION+ REDUC ACIDE 75mg COMP ALV 1x10

DIN 02247551

Tablet / Comprimé

Ranitidine 75 mg

632952B

Option+

OPTION+ REDUC ACIDE 75mg COMP ALV 4X10

DIN 02247551

Tablet / Comprimé

Ranitidine 75 mg

633694B

Option+

Option+ REDUC ACID F MAX 150mg CO ALV3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765G

Option+

Option+ REDUC ACID F MAX 150mg CO AL 1X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765B

Rexall Corp

Rexall Corp-REDUC ACIDE 150mg CO ALV 3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765F

Rexall Corp

Rexall Corp-REDUC ACIDE 150mg CO ALV 1X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765A

Biomedic

BIOMEDIC REDUC ACIDE 75mg COMP ALV 3X10

DIN 02247551

Tablet / Comprimé

Ranitidine 75 mg

632952I

Biomedic

BIOMEDIC-ACID RED F MAX 150mg COM ALV3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765I

Biomedic

BIOMEDIC-ACID RED F MAX 150mg COM ALV3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

628471C

LD

LD-REDUC ACIDE F MAX 150mg COMP ALV 3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765E

Pharmasave

PHARMASAVE-RED ACID F MAX 150mg CO AL1X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765C

Pharmasave

PHARMASAVE-RED ACID F MAX 150mg C ALV3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

628471B

Co-op Care +

CO-OP CARE + ACID REDU F M 150mg C AL3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

627765D

Compliments

Compliments-REDUC ACIDE 150mg C ALV 3X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

628471D

Health One

Health One-REDUC ACIDE 150mg COM ALV 4X8

DIN 02293471

Tablet / Comprimé

Ranitidine 150 mg

628471A

Personnelle

Personnelle-REDUC ACIDE 75mg CO ALV1X10

DIN 02247551

Tablet / Comprimé

Ranitidine 75 mg

632952D

LB

LB-REDUC D'ACIDE 75mg COMP ALV 3X10

DIN 02247551

Tablet / Comprimé

Ranitidine 75 mg

632952K

Issue

Presence of N-nitrosodimethylamine (NDMA) above the acceptable concentration limit in affected lots.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date: 2021-12-06
Alert / recall type
Health product recall
Category
Health product » Drugs
Companies

Pharmasience Inc.

Suite 100, 6111, Royalmount Avenue,

Montreal, Quebec

H4P 2T4

Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type I
Identification number
RA-63679